Hi all,
SRK has provided an update on the potential sale of its Peruvian iron ore assets. Based on today’s release and
discussion with management the transaction values the company at around $3.63/share after-tax. Tax implications remains the largest unknown, however our approach is conservative.
Retain a BUY with a price target of $4.49/share based on DCF valuation.
Note that the pre-tax valuation of the transaction (i.e. speculated purchase consideration) is $4.19/share which is roughly in line with price target.
- Forums
- ASX - By Stock
- SRK
- 4.54
4.54, page-24
Featured News
Add SRK (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.1¢ |
Change
0.001(3.33%) |
Mkt cap ! $8.796M |
Open | High | Low | Value | Volume |
3.1¢ | 3.4¢ | 3.1¢ | $675 | 21.25K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 83978 | 3.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.3¢ | 76808 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 83978 | 0.031 |
2 | 345960 | 0.028 |
2 | 92965 | 0.027 |
4 | 320371 | 0.025 |
1 | 100000 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.033 | 76808 | 1 |
0.036 | 51602 | 1 |
0.039 | 150000 | 1 |
0.040 | 136007 | 1 |
0.042 | 30000 | 1 |
Last trade - 15.58pm 15/11/2024 (20 minute delay) ? |
Featured News
SRK (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online